LSX World Congress

The agenda combines strategy-focused content with highly targeted networking to help companies build relationships, progress fundraising conversations, and accelerate collaborations across the life sciences ecosystem. A core feature is the structured approach to meetings, enabling delegates to turn the event into a dense, deal-oriented set of discussions rather than general conference networking.

Who the audience is and how many attend

Audience

• Biotech, medtech and pharmatech CEOs and C-suite leaders
• Business development and partnering teams
• Corporate venture and strategic investment groups
• Venture capital, growth equity and other healthcare investors
• Innovators and scale-ups seeking partners, capital and commercial pathways
• Service providers supporting growth (CROs/CDMOs, legal/IP, data/AI, commercial and regulatory partners)

Scale

• Qualified investors: 250+
• Decision-makers: 1,000+
• Format: Partnering/investment congress with structured networking and meeting functionality

What to expect

• A programme focused on life science strategy, partnering and capital formation
• High-density networking geared toward funders, founders and senior industry decision-makers
• Structured meeting opportunities designed to support efficient 1:1 conversations
• A Boston-based hub for cross-sector collaboration spanning biotech, medtech and pharmatech